1 Let’s Meet in Miami! INSIDE: Let’s Meet in Miami! What is iGlob? Meet a new ISOO Member MASCC/ISOO Guidelines April 2014 Greetings ISOO Members Looking forward to seeing you in Miami! Dr. Allan Hovan and Dr. Tanya Rouleau (Co-Editors, ISOO Newsletter) Please join us June 26-28 for the 2014 MASCC/ISOO International Symposium to be held in beautiful Miami Beach, USA! This year’s meeting promises to be bigger and better than ever. Stimulating presentations, the always sold-out Mucositis workshop, updates from the Oral Care Study Group, a dedicated ISOO CE Course……………..and a chance to meet up with friends and oncology colleagues from around the world. You won’t want to miss it!
3
Embed
Let’s Meet in Miami! · 2014. 4. 1. · 2013) explored taste dysfunction in people receiving chemotherapy. Her research reinforced that 'taste' is not taste. That is, the word 'taste'
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Let’s Meet in Miami!
INSIDE:
Let’s Meet in Miami!
What is iGlob?
Meet a new ISOO Member
MASCC/ISOO Guidelines
April 2014
Greetings ISOO MembersLooking forward to seeing you in Miami!
Dr. Allan Hovan and Dr. Tanya Rouleau(Co-Editors, ISOO Newsletter)
Please join us June 26-28 for the 2014 MASCC/ISOO International Symposium to be held in beautiful Miami Beach, USA! This year’s meeting promises to be bigger and better than ever. Stimulating presentations, the always sold-out Mucositis workshop, updates from the Oral Care Study Group, a dedicated ISOO CE Course……………..and a chance to meet up with friends and oncology colleagues from around the world. You won’t want to miss it!
2
I N T E R N A T I O N A L S O C I E T Y O F O R A L O N C O L O G Y N E W S L E T T E R
International Group for LLLT in Oncology (Barcelona)
A group of like-minded individuals with a range of expertise including radiation oncology, oral medicine, dentistry, physiotherapy and scientific research from four corners of our planet met in Barcelona in 2012 for intensive brainstorming which paved the way to the creation of the International Group of Low-Level Laser Therapy (LLLT) in Oncology-Barcelona or iGLOB.
The main goal of iGLOB is to study the potential of LLLT in supportive cancer of cancer patients, thereby improving and maintaining quality of life for various anticipated complications (oral mucositis, trismus, lymphoedema, GVHD and others). These potential complications may arise during active treatment and through survivorship. Our understanding of photomedicine using low-lever laser therapy is increasingly mechanistically based. We are in a much better position with regard to the use of LLLT in oral mucositis with the two recent guidelines from MASCC/ISOO recommending use in high dose chemotherapy for hematopoietic stem cell transplantation (HSCT) with or without total body irradiation (TBI) and a suggestion for prevention of oral mucositis in head and neck cancer treated with radiotherapy (RT) without concomitant chemotherapy. We are in the process of extensive literature reviews and streamlining LLLT parameters for specific conditions as well as planning well-designed randomized control trials around the globe.
The founding iGlobers are (please see the attached photograph) from left to right; Joseph Dominguez (Spain), Raj Nair (Australia), Rene-Jean Bensadoun (France), Ron Vanderbrink (USA), James Carroll (UK), Liset Linsaat (Netherlands), Judith Raber-Durlacher (Netherlands) and Joel Epstein (USA)